Inventor · disambiguated record
Yoshinobu Hashizume
Also filed as: HASHIZUME YOSHINOBU
7 granted patents·3 pending applications·91 citations·filing 2001–2017
85Inventor score
Top patents by PatentIndex Score
10 records- 0190US7479564B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsRAQUALIA PHARMA INC·Filed 2006·Granted Jan 20, 2009·21 cites·13 claims
- 0288US6710054B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsPFIZER·Filed 2001·Granted Mar 23, 2004·35 cites·16 claims
- 0385US7279486B2Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonistsPFIZER·Filed 2005·Granted Oct 9, 2007·11 cites·9 claims
- 0483US7141580B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsPFIZER·Filed 2004·Granted Nov 28, 2006·19 cites·12 claims
- 0572US7354925B2Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonistsPFIZER·Filed 2005·Granted Apr 8, 2008·3 cites·12 claims
- 0665US9604988B2Agent for treating or inhibiting recurrence of acute myeloid leukemiaRIKEN·Filed 2013·Granted Mar 28, 2017·2 cites·21 claims
- 0744US2008207665A1Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidinopropanoic Acid Compounds as Orl-1-Receptor AntagonistsPFIZER·Filed 2006·Application pending·0 cites
- 0843US2005153998A1Tetrahydroisoquinoline or isochroman compoundsFiled 2004·Application pending·0 cites
- 0941US2008200490A1Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidino Propanamide Compounds as Orl-1-Receptor AntagonistsPFIZER·Filed 2006·Application pending·0 cites
- 1037US10954216B2BMP-signal-inhibiting compoundRIKEN·Filed 2017·Granted Mar 23, 2021·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Yoshinobu Hashizume files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →